ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $48,000 | -23.8% | 12,985 | -41.8% | 0.00% | – |
| Q2 2018 | $63,000 | -30.0% | 22,330 | -7.9% | 0.00% | -100.0% |
| Q1 2018 | $90,000 | -17.4% | 24,234 | -35.9% | 0.00% | 0.0% |
| Q4 2017 | $109,000 | +14.7% | 37,796 | +220.7% | 0.00% | 0.0% |
| Q3 2016 | $95,000 | -19.5% | 11,786 | -22.3% | 0.00% | 0.0% |
| Q2 2016 | $118,000 | +13.5% | 15,173 | +13.0% | 0.00% | 0.0% |
| Q1 2016 | $104,000 | -3.7% | 13,424 | +34.6% | 0.00% | 0.0% |
| Q4 2015 | $108,000 | +27.1% | 9,972 | -18.6% | 0.00% | 0.0% |
| Q3 2015 | $85,000 | +157.6% | 12,255 | +229.5% | 0.00% | – |
| Q2 2015 | $33,000 | +13.8% | 3,719 | +28.6% | 0.00% | – |
| Q1 2015 | $29,000 | +16.0% | 2,891 | +42.8% | 0.00% | – |
| Q4 2014 | $25,000 | +4.2% | 2,025 | -16.8% | 0.00% | – |
| Q3 2014 | $24,000 | +26.3% | 2,434 | -2.5% | 0.00% | – |
| Q2 2014 | $19,000 | +111.1% | 2,497 | -8.9% | 0.00% | – |
| Q1 2014 | $9,000 | 0.0% | 2,740 | +1.3% | 0.00% | – |
| Q4 2013 | $9,000 | -67.9% | 2,705 | -70.6% | 0.00% | – |
| Q3 2013 | $28,000 | -30.0% | 9,199 | +90.3% | 0.00% | – |
| Q2 2013 | $40,000 | – | 4,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |